Fractional Chief Revenue Officer — Life Sciences
I spent 30 years leading commercial teams at AstraZeneca. Now I help biotech and specialty pharma companies get ready to launch, fix revenue problems, and get their teams pulling in the same direction, without hiring a full-time executive.
If you're getting close to a launch, behind on your numbers, or in the middle of a reorganization, I can tell you where your commercial engine stands and what to fix first. It takes 30 days. You get a written report and a working session with your leadership team.
The fee is $12,500, fixed — half to start, half on delivery. There's no retainer and no follow-on commitment. If you want ongoing help afterward, we'll talk about it then.
Book the assessmentI spent just over three decades at AstraZeneca, plus two years in biotech, leading sales, marketing, medical affairs, and operations across several therapeutic areas, in the U.S. and globally. I've taken products through launch, rebuilt commercial organizations, and led some very large transformations. I've seen what works and what doesn't, usually the hard way.
These days I work as a fractional revenue leader for life sciences companies at inflection points: a first launch, missed numbers, a reorganization. The rule I've kept from 30 years of doing this is simple — people before projects.
Member of Life Sciences Pennsylvania and BioBreak Philadelphia. Executive coursework at MIT Sloan (AI & Business Strategy) and Wharton (Medical Executive Leadership). Based outside Philadelphia; I work nationally.
I also founded and chair LSCR, a network of senior biotech and pharma consultants. It's separate from my consulting work, but it keeps me current on what's actually working across the industry. And if what you need is a specialist rather than a commercial leader, it's a good place to start.